Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women

  • Technology appraisal guidance
  • TA161
  • Published: 
  • Last updated: 

Addendum to the Assessment Report

Additional ICERs including assumptions on the effect of acid suppressive medications, extraced from the Assessment Groups spreadsheets by the technical team

This page was last updated: 30 March 2010